Aggrifib Injection
Prescription Required
Product introduction
Aggrifib Injection is a blood thinner which prevents formation of harmful blood clots. It helps to prevent a heart attack in patients presenting with severe chest pain due to a sudden decrease in blood flow to the heart.
Aggrifib Injection is used to prevent blood flow complications during an angioplasty and even in general
Aggrifib Injection is used to prevent blood flow complications during an angioplasty and even in general
Uses of Aggrifib Injection
Benefits of Aggrifib Injection
In Prevention of Heart attack
It prevents blood from clotting inside the veins and arteries. This helps the blood flow freely around your body thereby preventing a heart attack or stroke (or deep vein thrombosis or pulmonary embolism). Follow your doctor’s instructions carefully and make appropriate lifestyle changes (such as eating healthy and staying active) to maximize the effectiveness of this medicine.
Side effects of Aggrifib Injection
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Aggrifib
- Headache
- Nausea
- Hematoma
- Ecchymosis (discoloration of the skin resulting from bleeding underneath)
- Postoperative bleeding
- Blood in stool
- Blood in urine
How to use Aggrifib Injection
Your doctor or nurse will give you this medicine. Kindly do not self administer.
Safety advice
Alcohol
CONSULT YOUR DOCTOR
It is not known whether it is safe to consume alcohol with Aggrifib Injection. Please consult your doctor.
Pregnancy
SAFE IF PRESCRIBED
Aggrifib Injection is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Breast feeding
CAUTION
Aggrifib Injection should be used with caution during breastfeeding. Breastfeeding should be held until the treatment of the mother is completed and the drug is eliminated from her body.
Driving
NOT RELEVANT
Not relevant, as Aggrifib Injection is intended for use in hospitalised patients.
Kidney
CAUTION
Aggrifib Injection should be used with caution in patients with kidney disease. Dose adjustment of Aggrifib Injection may be needed. Please consult your doctor.
Liver
CAUTION
Aggrifib Injection should be used with caution in patients with liver disease. Dose adjustment of Aggrifib Injection may be needed. Please consult your doctor.
Use of Aggrifib Injection is not recommended in patients with severe liver disease.
Use of Aggrifib Injection is not recommended in patients with severe liver disease.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
No substitutes found for this medicine
Quick tips
- It increases your risk of bleeding. Be careful while shaving, cutting fingernails or toenails or using sharp objects.
- Notify your doctor if you see blood in your vomit, urine or stool (black, tarry stools or bright red blood).
Fact Box
Chemical Class
Phenylalanine derivatives
Habit Forming
No
Therapeutic Class
BLOOD RELATED
Action Class
Glycoprotein IIb/IIIa inhibitors
Patient concerns
FAQs
Can the use of Aggrifib Injection increase the risk of bleeding?
Yes, Aggrifib Injection increases the risk of bleeding. Always be careful while doing activities that may cause an injury or bleeding. Tell your doctor immediately if you notice any abnormal bruising or bleeding.
What medicines should I avoid while taking Aggrifib Injection?
Aggrifib Injection can interact with several medicines. Do not take any medicine without talking to your doctor.
When will I feel better after taking Aggrifib Injection?
Aggrifib Injection reduces your risk of developing blood clots in the blood vessels of your leg, lungs, heart and brain. You may not feel any difference after taking Aggrifib Injection. However, keep taking this medicine as prescribed by your doctor because you will still be getting its full benefits.
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Weitz JI. Blood Coagulation and Anticoagulant, Fibrinolytic, and Antiplatelet Drugs. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 871-72.
- Fox KA, White HD, Gersh BJ, et al. Antithrombotic Agents: Platelete Inhibitors, Acute Anticoagulants, Fibrinolytics, and Chronic Anticoagulants. In: Opie LH, Gersh BJ, editors. Drugs for the Heart. 8th ed. Philadelphia, Pennsylvania: Elsevier Saunders; 2013. p. 355.
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 1369-70.
- Central Drugs Standard Control Organisation (CDSCO). [Accessed 19 Mar. 2019] (online) Available from:
- Tirofiban hydrochloride monohydrate. Uxbridge, UK: Correvio UK Ltd.; 1999 [03 Dec. 2014]. [Accessed 24 Jan. 2019] (online) Available from:
Marketer details
Name: Aprica Pharmaceuticals Pvt Ltd
Address: A/4 4th Floor, Safal Profitaire,Corporate Road,Nr Prahladnagar Garden, Prahladnagar,Ahmedabad- 380015, Gujarat, India.
Country of origin: India
Lab tests offered by us
Related/Popular tests
MRP
₹5442
Inclusive of all taxes
100.0 ml in 1 vial
SOLD OUT
Notify me